OPKO Health Net Profit Margin 2010-2025 | OPK
OPKO Health net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
| OPKO Health Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-03-31 | $0.69B | $-0.04B | -5.65% |
| 2024-12-31 | $0.71B | $-0.05B | -7.42% |
| 2024-09-30 | $0.71B | $-0.13B | -18.68% |
| 2024-06-30 | $0.72B | $-0.24B | -33.75% |
| 2024-03-31 | $0.80B | $-0.25B | -31.50% |
| 2023-12-31 | $0.86B | $-0.19B | -21.76% |
| 2023-09-30 | $0.87B | $-0.21B | -23.88% |
| 2023-06-30 | $0.87B | $-0.21B | -24.08% |
| 2023-03-31 | $0.91B | $-0.29B | -31.87% |
| 2022-12-31 | $1.00B | $-0.33B | -32.67% |
| 2022-09-30 | $1.22B | $-0.32B | -25.98% |
| 2022-06-30 | $1.43B | $-0.20B | -14.17% |
| 2022-03-31 | $1.56B | $-0.12B | -7.45% |
| 2021-12-31 | $1.77B | $-0.03B | -1.69% |
| 2021-09-30 | $1.87B | $0.08B | 4.07% |
| 2021-06-30 | $1.91B | $0.07B | 3.72% |
| 2021-03-31 | $1.77B | $0.12B | 6.84% |
| 2020-12-31 | $1.44B | $0.03B | 2.16% |
| 2020-09-30 | $1.16B | $-0.11B | -9.71% |
| 2020-06-30 | $0.97B | $-0.20B | -20.62% |
| 2020-03-31 | $0.89B | $-0.29B | -32.92% |
| 2019-12-31 | $0.90B | $-0.32B | -34.96% |
| 2019-09-30 | $0.90B | $-0.28B | -31.03% |
| 2019-06-30 | $0.92B | $-0.25B | -26.63% |
| 2019-03-31 | $0.96B | $-0.19B | -19.94% |
| 2018-12-31 | $0.99B | $-0.15B | -15.44% |
| 2018-09-30 | $0.93B | $-0.30B | -31.72% |
| 2018-06-30 | $0.93B | $-0.30B | -32.72% |
| 2018-03-31 | $0.96B | $-0.31B | -32.88% |
| 2017-12-31 | $0.97B | $-0.31B | -31.68% |
| 2017-09-30 | $0.98B | $-0.13B | -12.81% |
| 2017-06-30 | $1.03B | $-0.10B | -10.12% |
| 2017-03-31 | $1.09B | $-0.07B | -6.50% |
| 2016-12-31 | $1.12B | $-0.05B | -4.30% |
| 2016-09-30 | $1.22B | $-0.01B | -0.74% |
| 2016-06-30 | $1.07B | $0.13B | 12.56% |
| 2016-03-31 | $0.75B | $0.08B | 9.97% |
| 2015-12-31 | $0.49B | $-0.03B | -6.11% |
| 2015-09-30 | $0.24B | $-0.09B | -35.27% |
| 2015-06-30 | $0.12B | $-0.26B | -222.03% |
| 2015-03-31 | $0.10B | $-0.24B | -244.00% |
| 2014-12-31 | $0.09B | $-0.17B | -186.96% |
| 2014-09-30 | $0.09B | $-0.14B | -156.32% |
| 2014-06-30 | $0.09B | $-0.15B | -167.05% |
| 2014-03-31 | $0.09B | $-0.13B | -142.05% |
| 2013-12-31 | $0.10B | $-0.12B | -118.56% |
| 2013-09-30 | $0.09B | $-0.10B | -107.61% |
| 2013-06-30 | $0.08B | $-0.05B | -59.04% |
| 2013-03-31 | $0.07B | $-0.06B | -82.61% |
| 2012-12-31 | $0.05B | $-0.03B | -65.96% |
| 2012-09-30 | $0.04B | $-0.01B | -32.43% |
| 2012-06-30 | $0.03B | $-0.01B | -34.38% |
| 2012-03-31 | $0.03B | $-0.01B | -20.00% |
| 2011-12-31 | $0.03B | $0.00B | -10.71% |
| 2011-09-30 | $0.03B | $-0.02B | -75.86% |
| 2011-06-30 | $0.03B | $-0.02B | -75.00% |
| 2011-03-31 | $0.03B | $-0.02B | -81.48% |
| 2010-12-31 | $0.03B | $-0.02B | -75.00% |
| 2010-09-30 | $0.02B | $-0.03B | -157.89% |
| 2010-06-30 | $0.02B | $-0.03B | -213.33% |
| 2010-03-31 | $0.01B | $-0.03B | -310.00% |
| 2009-12-31 | $0.00B | $-0.04B | -875.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.071B | $0.713B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $183.069B | 22.15 |
| Intuitive Surgical (ISRG) | United States | $177.069B | 73.39 |
| Edwards Lifesciences (EW) | United States | $46.042B | 30.54 |
| IDEXX Laboratories (IDXX) | United States | $45.559B | 52.36 |
| Alcon (ALC) | Switzerland | $44.466B | 30.05 |
| DexCom (DXCM) | United States | $35.105B | 54.26 |
| IQVIA Holdings (IQV) | United States | $33.619B | 19.00 |
| Mettler-Toledo (MTD) | United States | $26.208B | 31.17 |
| STERIS (STE) | Ireland | $22.284B | 24.54 |
| Waters (WAT) | United States | $17.993B | 25.39 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.253B | 0.00 |
| Hologic (HOLX) | United States | $14.639B | 15.91 |
| Sysmex ADR (SSMXY) | Japan | $10.588B | 30.04 |
| Penumbra (PEN) | United States | $8.914B | 69.96 |
| Masimo (MASI) | United States | $8.793B | 32.44 |
| Globus Medical (GMED) | United States | $7.351B | 17.52 |
| Glaukos (GKOS) | United States | $5.424B | 0.00 |
| Teleflex (TFX) | United States | $5.106B | 8.43 |
| Integer Holdings (ITGR) | United States | $3.789B | 18.91 |
| TransMedics (TMDX) | United States | $3.560B | 77.38 |
| PROCEPT BioRobotics (PRCT) | United States | $2.992B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.370B | 14.11 |
| Veracyte (VCYT) | United States | $1.959B | 27.50 |
| Elekta AB (EKTAY) | Sweden | $1.933B | 17.38 |
| Nihon Kohden (NHNKY) | Japan | $1.911B | 21.92 |
| Alphatec Holdings (ATEC) | United States | $1.636B | 0.00 |
| Artivion (AORT) | United States | $1.337B | 125.24 |
| Tandem Diabetes Care (TNDM) | United States | $1.122B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.023B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.018B | 5.41 |
| SiBone (SIBN) | United States | $0.750B | 0.00 |
| IRadimed (IRMD) | United States | $0.726B | 36.85 |
| Beta Bionics (BBNX) | United States | $0.607B | 0.00 |
| AxoGen (AXGN) | United States | $0.592B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.555B | 8.64 |
| OrthoPediatrics (KIDS) | United States | $0.544B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.541B | 11.65 |
| Pacific Biosciences Of California (PACB) | United States | $0.492B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.447B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.425B | 9.88 |
| Delcath Systems (DCTH) | United States | $0.397B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.371B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.362B | 0.00 |
| RxSight (RXST) | United States | $0.320B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.307B | 0.00 |
| Neuronetics (STIM) | United States | $0.299B | 0.00 |
| NeuroPace (NPCE) | United States | $0.287B | 0.00 |
| 908 Devices (MASS) | United States | $0.263B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.254B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.245B | 14.82 |
| CVRx (CVRX) | United States | $0.220B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.203B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.183B | 0.00 |
| Inogen (INGN) | United States | $0.183B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.182B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| Accuray (ARAY) | United States | $0.143B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.125B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.121B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.118B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.106B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.106B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.087B | 53.20 |
| Hyperfine (HYPR) | United States | $0.086B | 0.00 |
| InspireMD (NSPR) | United States | $0.075B | 0.00 |
| Spectral AI (MDAI) | United States | $0.070B | 0.00 |
| Positron (POSC) | United States | $0.061B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.058B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.057B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.055B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 20.78 |
| WORK Medical Technology Group (WOK) | China | $0.046B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.014B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 14.76 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |